Holen Sie sich die Stockscreener-App
0.3575
1.94%
0.0068
Schlusskurs vom Vortag:
$0.3507
Offen:
$0.3509
24-Stunden-Volumen:
4,287
Relative Volume:
0.01
Marktkapitalisierung:
$12.39M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-7.60M
KGV:
-1.5721
EPS:
-0.2274
Netto-Cashflow:
$-6.74M
1W Leistung:
-5.22%
1M Leistung:
-36.98%
6M Leistung:
-77.52%
1J Leistung:
-52.27%
1-Tages-Spanne:
$0.3507
$0.3642
1-Wochen-Bereich:
$0.33
$0.43
52-Wochen-Spanne:
$0.33
$3.33
Jupiter Neurosciences Inc Stock (JUNS) Company Profile
Firmenname
Jupiter Neurosciences Inc
Sektor
Branche
Telefon
(561) 406-6154
Adresse
1001 NORTH US HWY 1, JUPITER
Compare JUNS vs VRTX, REGN, ALNY, ARGX, INSM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
JUNS
Jupiter Neurosciences Inc
|
0.3599 | 12.07M | 0 | -7.60M | -6.74M | -0.2274 |
VRTX
Vertex Pharmaceuticals Inc
|
452.38 | 115.58B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
754.66 | 79.23B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
329.83 | 43.59B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
687.64 | 43.26B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
147.26 | 31.97B | 606.42M | -1.28B | -997.58M | -6.403 |
Jupiter Neurosciences Inc Aktie (JUNS) Neueste Nachrichten
Buyback Watch: Can ACDC expand its profit margins2026 Catalysts & Real-Time Volume Trigger Notifications - baoquankhu1.vn
Aug Patterns: Is Jupiter Neurosciences Inc benefiting from interest rate changesShort Setup & Long-Term Safe Investment Plans - baoquankhu1.vn
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
If You Invested $1,000 in JUPITER NEUROSCIENCES, INC. (JUNS) - Stock Titan
Will Jupiter Neurosciences Inc benefit from geopolitical trendsMarket Risk Report & Safe Swing Trade Setup Alerts - baoquankhu1.vn
Jupiter Neurosciences, Inc.: Fundamental Analysis and Financial Ratings | JUNS | US48208B2034 - marketscreener.com
JUNS Forecast, Price Target & Analyst Ratings | JUPITER NEUROSCIENCES INC (NASDAQ:JUNS) - ChartMill
CEO Moves: Is Jupiter Neurosciences Inc benefiting from interest rate changesWeekly Profit Recap & Fast Gain Stock Tips - baoquankhu1.vn
Market Overview: Can Jupiter Neurosciences Inc. reach all time highs this yearGap Up & Scalable Portfolio Growth Methods - baoquankhu1.vn
Trading Action: Is Jupiter Neurosciences Inc forming a double bottomMarket Movers & Weekly High Return Forecasts - baoquankhu1.vn
Bull Bear: What is the earnings history of Jupiter Neurosciences IncTrend Reversal & Technical Buy Zone Confirmations - baoquankhu1.vn
Momentum Shift: How do insiders feel about Jupiter Neurosciences IncJuly 2025 PostEarnings & Weekly Breakout Watchlists - baoquankhu1.vn
Buyback Watch: Will Jupiter Neurosciences Inc face regulatory challengesJuly 2025 Big Picture & Daily Profit Focused Screening - baoquankhu1.vn
Aug Rallies: Can Jupiter Neurosciences Inc scale operations efficientlyJuly 2025 Selloffs & Expert Curated Trade Setup Alerts - baoquankhu1.vn
JUNS Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Jupiter Neurosciences to Present at BIO Investment and Growth Summit 2026 - mydailyrecord.com
Parkinson’s trial and Nugevia revenue put Jupiter Neurosciences on BIO stage - Stock Titan
JUNS Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Jupiter Neurosciences Receives Nasdaq Deficiency Notices, Faces Delisting - TipRanks
Jupiter Neurosciences Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Jupiter Neurosciences (JUNS) faces Nasdaq bid price and $35M value shortfall - Stock Titan
Jupiter Neurosciences Invited to Present Clinical and Commercial Progress at Investor Dinner at Mar-a-Lago - BioSpace
Chipmakers Recap: Does Sun Life Financial Inc stock have upside surprise potentialWeekly Trade Analysis & Consistent Return Strategy Ideas - baoquankhu1.vn
Jupiter Neurosciences Amends Yorkville Installment Provisions to Align Capital With Clinical and Commercial Execution - Delawareonline.com
Yorkville defers $6M to 2026 as Jupiter pushes Nugevia sales, Parkinson’s program - Stock Titan
JUNSJUPITER NEUROSCIENCES, INC. Latest Stock News & Market Updates - Stock Titan
Aug PostEarnings: How sensitive is HSTM to inflationTrade Volume Summary & Low Drawdown Investment Strategies - baoquankhu1.vn
Jupiter Neurosciences Amends Yorkville Financing Agreement Terms - TipRanks
Can Jupiter Neurosciences Inc. stock attract ESG capital inflowsMarket Rally & AI Forecasted Entry and Exit Points - mfd.ru
What is the earnings history of Jupiter Neurosciences Inc.Trade Entry Report & Weekly Watchlist for Consistent Profits - mfd.ru
Jupiter Neuroscience and ANNIKA Women’s All Pro Tour Announce Multi-Year Partnership - The Golf Wire
Can Jupiter Neurosciences Inc reach resistance levels soon2025 Dividend Review & Low Risk High Win Rate Picks - baoquankhu1.vn
Big Picture: What is the next catalyst for Jupiter Neurosciences Inc.July 2025 Drop Watch & Reliable Breakout Stock Forecasts - mfd.ru
Aug Wrap: Can Jupiter Neurosciences Inc. stock attract ESG capital inflowsInsider Selling & Long-Term Growth Plans - mfd.ru
Analyst Upgrade: Should I average down on PTPI stock2025 Trade Ideas & AI Forecasted Entry and Exit Points - baoquankhu1.vn
Jupiter Neurosciences Selected as B2i Digital Featured Company - The Progress Index
Can Jupiter Neurosciences Inc. reach all time highs this year2025 Retail Activity & Growth Oriented Trading Recommendations - mfd.ru
Jupiter Neurosciences Selected as B2i Digital Featured Company Amid Parkinson's Trial and Consumer Brand Expansion - citybuzz -
Signal Recap: What analysts say about Jupiter Neurosciences Inc stockWeekly Investment Recap & Low Risk Profit Maximizing Plans - baoquankhu1.vn
Jupiter Neurosciences Selected as B2i Digital Featured Company | Corporate - EQS News
Will Jupiter Neurosciences Inc. stock attract more institutional investors2025 Risk Factors & High Accuracy Swing Trade Signals - mfd.ru
Travel Stocks: Is Jupiter Neurosciences Inc currently under institutional pressureTrade Entry Report & AI Powered Market Entry Ideas - baoquankhu1.vn
Aug Analyst Calls: Is Jupiter Neurosciences Inc in a long term uptrendJuly 2025 Retail & Trade Opportunity Analysis Reports - baoquankhu1.vn
Dow Update: Will Cineverse Corp outperform tech stocksM&A Rumor & Weekly High Return Stock Forecasts - baoquankhu1.vn
Jupiter Neurosciences Expands Nugevia™ Addressable Market with Focus on GLP-1 Users - The Desert Sun
Aug Reactions: Will Whitehawk Therapeutics Inc outperform tech stocks2025 Price Action Summary & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn
Gains Recap: Does Verde Clean Fuels Inc. have strong EBITDA marginsMarket Weekly Review & AI Forecasted Stock Moves - baoquankhu1.vn
Jupiter Neurosciences launches support initiative for GLP-1 users By Investing.com - Investing.com Nigeria
Jupiter Neurosciences Expands Nugevia™ Addressable Market With Focus On GLP-1 Users - Tampa Free Press
Portfolio Recap: What analysts say about ALCY stockCPI Data & Community Verified Watchlist Alerts - baoquankhu1.vn
Jupiter Neurosciences Expands Nugevia Addressable Market with Focus on GLP-1 Users - marketscreener.com
Finanzdaten der Jupiter Neurosciences Inc-Aktie (JUNS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.99%
3.03%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):